Abstract:Introduction: Congenital myasthenic syndromes (CMS) are a diverse group of inherited neuromuscular disorders characterized by a failure of synaptic transmission at the neuromuscular junction (NMJ). CMS often present early with fatigable weakness and can be fatal through respiratory complications. The AGRN gene is one of over 30 genes known to harbor mutations causative for CMS. In this study, we aimed to determine if a compound (NT1654), developed to stimulate the acetylcholine receptor (AChR) clustering pathway, would benefit a mouse model of CMS caused by a loss-of-function mutation in Agrn ( Agrn nmf380 mouse). Methods: Agrn nmf380 mice received an injection of either NT1654 or vehicle compound daily, with wild-type litter mates used for comparison. Animals were weighed daily and underwent grip strength assessments. After 30 days of treatment animals were sacrificed, and muscles collected. Investigations into NMJ and muscle morphology were performed on collected tissue. Results: While minimal improvements in NMJ ultrastructure were observed with electron microscopy, gross NMJ structure analysis using fluorescent labelling and confocal microscopy revealed extensive postsynaptic improvements in Agrn nmf380 mice with NT1654 administration, with variables frequently returning to wild type levels. An improvement in muscle weight and myofiber characteristics helped increase forelimb grip strength and body weight. Conclusions: We conclude that NT1654 restores NMJ postsynaptic structure and improves muscle strength through normalization of muscle fiber composition and the prevention of atrophy. We hypothesize this occurs through the AChR clustering pathway in Agrn nmf380 mice. Future studies should investigate if this may represent a viable treatment option for patients with CMS, especially those with mutations in proteins of the AChR clustering pathway.

Muscle-wide Secretion of a Miniaturized Form of Neural Agrin Rescues Focal Neuromuscular Innervation in Agrin Mutant Mice.

Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers

The Role of Nerve- Versus Muscle-Derived Factors in Mammalian Neuromuscular Junction Formation

Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin- 2-deficient mice

An Agrin Minigene Rescues Dystrophic Symptoms in a Mouse Model for Congenital Muscular Dystrophy

Differential Regulation of AChR Clustering in the Polar and Equatorial Region of Murine Muscle Spindles.

Structural basis of agrin-LRP4-MuSK signaling.

Synapse Loss in Cortex of Agrin-Deficient Mice after Genetic Rescue of Perinatal Death.

Neuromuscular synapse formation in mice lacking motor neuron- and skeletal muscle-derived Neuregulin-1

Injection of a Soluble Fragment of Neural Agrin (NT-1654) Considerably Improves the Muscle Pathology Caused by the Disassembly of the Neuromuscular Junction

APC2CDH1negatively Regulates Agrin Signaling by Promoting the Ubiquitination and Proteolytic Degradation of DOK7

Agrin/Lrp4 signal constrains MuSK-dependent neuromuscular synapse development in appendicular muscle

Implication of Geranylgeranyltransferase I in Synapse Formation

The Ig1/2 domain of MuSK binds to muscle surface and is involved in acetylcholine receptor clustering.

A Mechanism in Agrin Signaling Revealed by a Prevalent Rapsyn Mutation in Congenital Myasthenic Syndrome.

Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome

A link between agrin signalling and Cav3.2 at the neuromuscular junction in spinal muscular atrophy

Crosstalk Between Agrin and Wnt Signaling Pathways in Development of Vertebrate Neuromuscular Junction.

Identification of the Downstream Molecules of Agrin/dok‐7 Signaling in Muscle

MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.

Agrin Regulates Growth Cone Turning of Xenopus Spinal Motoneurons